When scientists, entrepreneurs and others involved in the biofuels industry converged in San Diego during the second week of October for the third annual Algae Biomass Summit, they struck a decidedly different note compared with the first two years of the summit.   

Revolutionizing the way vaccines are delivered is Joseph Kim's goal as president and chief executive officer of Inovio Biomedical.   

For Gail Naughton, one of the most exciting things about her company Histogen's recent clinical trial is just how fast they're seeing results.   

Aerotek Inc., a leading U.S. staffing provider, is a direct source to provide valuable staffing services within the San Diego business community. As a key staffing partner throughout the San Diego community for more than 14 years, Aerotek's experienced staffing professionals locate, screen and place candidates in positions for a variety of industries, including the biotech industry.   

The European Union approved Merck & Co.'s (NYSE: MRK) proposed takeover of Schering-Plough (NYSE: SGP), which would create the second-biggest global producer of prescription medicines.   

GE Healthcare said Wednesday it plans to expand a cancer drug research partnership with Eli Lilly & Co. (NYSE: LLY), making a two-year-old partnership official in the process.   

There are some life experiences few will ever have. And as the oldest of nine children and CEO of a Fortune 500 company, John Lechleiter has a couple under his belt.   

The San Diego laboratory market consists of approximately 14 million square feet, with countywide vacancy at 10.3 percent, remaining flat since the end of second-quarter 2009.   

When it comes to an emergency response to a bioterrorism attack, San Diego is doing its part to be prepared.   

The future of food production may not have to involve genetically altered crops or chemically enhanced plants, thanks to an enterprising San Diego company.   

   

The Bill & Melinda Gates Foundation included two local research projects in its recent round of funding for its Grand Challenges Explorations program.   

Lpath (OTC: LPTN), which specializes in lipid-based therapeutics, has been awarded two Phase 1 grants totaling $300,000 from the National Cancer Institute's Small Business Innovation Research (SBIR) Program.   

   

On Monday, Ardea Biosciences Inc. (Nasdaq: RDEA) announced additional positive results from an ongoing study of its treatment for hyperuricemia and gout.   

San Diego bucked the national venture capital trend in the third quarter, posting a 20-percent increase in dollars attracted while the U.S. average stalled, according to a report from industry tracker Dow Jones VentureSource.   

Quidel Corp. (Nasdaq: QDEL), a San Diego-based provider of rapid point-of-care diagnostic tests, has launched its MicroVue C5a EIA Kit for research use only.   

Acadia Pharmaceuticals (Nasdaq: ACAD) plans to cut its work force in half after disappointing results from its Phase 3 trial with Parkinson's psychosis treatment pimavanserin.   

Stemedica Cell Technologies Inc. announced Thursday that it has completed meetings with the FDA and plans to go ahead with studies on a new stroke treatment.   

Cardium Therapeutics (NYSE Amex: CXM) has announced a registered direct offering of common stock to selected investors for aggregate gross proceeds of $6.0 million.   

La Jolla Pharmaceutical Co. (Nasdaq: LJPC) has set a date for its stockholders to vote on whether to liquidate the practically defunct biotech.   

Local intellectual property attorneys are applauding last week's decision by the U.S. Patent & Trademark Office to rescind its proposed rules changes.   

From airplane wings to fan blades to the eye black athletes wear to deflect the sun, mankind has been modeling its products after the natural world since it started making products in the first place.   

The U.S. Navy has awarded Vical Inc. (Nasdaq: VICL) a contract for $1.25 million to support a Phase 1 clinical trial of the company's vaccine for H1N1 influenza, more commonly known as swine flu.